WO2009001787A1 - 補酵素ｑ１０含有組成物 - Google Patents

補酵素ｑ１０含有組成物 Download PDF

Info

Publication number
WO2009001787A1
WO2009001787A1 PCT/JP2008/061364 JP2008061364W WO2009001787A1 WO 2009001787 A1 WO2009001787 A1 WO 2009001787A1 JP 2008061364 W JP2008061364 W JP 2008061364W WO 2009001787 A1 WO2009001787 A1 WO 2009001787A1
Authority
WO
WIPO (PCT)
Prior art keywords
food
composition containing
drug
composition
containing coenzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/061364
Other languages
English (en)
French (fr)
Inventor
Toshinori Ikehara
Takayuki Sakogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Priority to DK08765784.7T priority Critical patent/DK2172196T3/da
Priority to ES08765784T priority patent/ES2787229T3/es
Priority to JP2009520569A priority patent/JP5377304B2/ja
Priority to EP08765784.7A priority patent/EP2172196B1/en
Publication of WO2009001787A1 publication Critical patent/WO2009001787A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)

Abstract

　本発明は、優れた水分散性／溶解性、作業性、打錠性を有する、特定割合の補酵素Ｑ１０、カゼイン類および多糖類以外の糖類を含有する組成物を提供する。該組成物は食品、栄養機能食品、特定保健用食品、栄養補助剤、栄養剤、動物薬、飲料、飼料、医薬品、医薬部外品、化粧品などに利用することができる。 
PCT/JP2008/061364 2007-06-22 2008-06-20 補酵素ｑ１０含有組成物 Ceased WO2009001787A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DK08765784.7T DK2172196T3 (da) 2007-06-22 2008-06-20 Sammensætning indeholdende coenzym q10
ES08765784T ES2787229T3 (es) 2007-06-22 2008-06-20 Composición que contiene coenzima Q10
JP2009520569A JP5377304B2 (ja) 2007-06-22 2008-06-20 補酵素ｑ１０含有組成物
EP08765784.7A EP2172196B1 (en) 2007-06-22 2008-06-20 Composition containing coenzyme q10

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007165176 2007-06-22
JP2007-165176 2007-06-22
US99615707P 2007-11-05 2007-11-05
US60/996,157 2007-11-05

Publications (1)

Publication Number Publication Date
WO2009001787A1 true WO2009001787A1 (ja) 2008-12-31

Family

ID=40160806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/061364 Ceased WO2009001787A1 (ja) 2007-06-22 2008-06-20 補酵素ｑ１０含有組成物

Country Status (5)

Country Link
US (1) US20090004170A1 (ja)
EP (1) EP2172196B1 (ja)
JP (1) JP5377304B2 (ja)
TW (1) TW200916090A (ja)
WO (1) WO2009001787A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011055805A (ja) * 2009-09-14 2011-03-24 Sanei Gen Ffi Inc 魚肉の着色方法
JP2012522835A (ja) * 2009-04-06 2012-09-27 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー コエンザイムｑ１０ナノ粒子、その製造方法及び上記ナノ粒子を含む組成物
WO2015186729A1 (ja) * 2014-06-03 2015-12-10 カルピス株式会社 錠剤型即放性製剤、錠剤用組成物及び錠剤型即放性製剤の製造方法
JP2024517556A (ja) * 2021-03-17 2024-04-23 ユ，ヒョギョン コエンザイムｑ１０含有液状補助飼料組成物

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200918096A (en) * 2007-06-22 2009-05-01 Kaneka Corp Composition comprising bioactive substance
EP2186789B1 (en) * 2007-08-22 2013-12-25 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
US8496948B2 (en) * 2009-12-02 2013-07-30 Bath And Body Works Brand Management, Inc. Topical skin composition comprising mineral yeast ferments
WO2011132718A1 (ja) * 2010-04-20 2011-10-27 株式会社カネカ 還元型補酵素ｑ１０含有組成物とその製造方法及び安定化方法
US9168308B2 (en) 2011-04-22 2015-10-27 Paul Joseph FAERSTEIN Compositions and methods for nutritional supplementation
ITUD20110196A1 (it) * 2011-12-02 2013-06-03 Asoltech S R L Composizione a base di ubidecarenone
EP2666365A1 (en) * 2012-05-22 2013-11-27 Taminco Treatment of poultry, pigs or fish for reducing the feed conversion ratio.
CN111449170A (zh) * 2020-04-09 2020-07-28 苏州丰倍生物科技有限公司 一种饲用液体营养添加剂及其制备方法和应用
CN112056560A (zh) * 2020-09-18 2020-12-11 烟台硕人生物科技有限公司 一种辅酶q10和褐藻寡糖氧化复合颗粒的制备方法
CN112401067A (zh) * 2020-09-27 2021-02-26 天津农学院 一种提高蛋黄中辅酶q10沉积量的饲料添加剂及其应用
CN115804759B (zh) * 2022-12-09 2024-05-10 江苏扬新生物医药有限公司 一种含有辅酶q10和钙的颗粒剂
CN116036060B (zh) * 2023-02-14 2025-09-26 厦门金达威生物科技有限公司 一种辅酶q10油剂及其制备方法和应用
CN116693716B (zh) * 2023-04-28 2024-07-19 湖北医药学院 一种金果榄多糖及其制备方法和应用

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754116A (ja) * 1980-09-19 1982-03-31 Eisai Co Ltd Bunsannoyoicoq10ganjusoseibutsu
EP0065193A2 (de) * 1981-05-15 1982-11-24 BASF Aktiengesellschaft Verfahren zur Herstellung von feinverteilten, pulverförmigen Carotinoid- bzw. Retinoidpräparaten
JPS5951214A (ja) 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
JP2000212066A (ja) 1998-11-16 2000-08-02 Eisai Co Ltd 脂溶性物質の水性液剤
JP2003055203A (ja) 2001-08-10 2003-02-26 Nisshin Pharma Inc ユビキノン含有製剤
JP2003169630A (ja) * 2001-09-25 2003-06-17 Nisshin Pharma Inc コエンザイムｑ１０を含有する栄養組成物
JP2003238396A (ja) 2002-02-21 2003-08-27 Nisshin Pharma Inc コエンザイムｑ１０含有乳化組成物
JP2003321352A (ja) * 2002-04-24 2003-11-11 Nisshin Pharma Inc コエンザイムｑ１０含有組成物
JP2004075664A (ja) * 2002-06-20 2004-03-11 Nisshin Kyorin Pharmaceutical Co Ltd コエンザイムｑ１０を含有する経管経腸栄養剤
JP2005524635A (ja) * 2002-02-08 2005-08-18 アボット ゲーエムベーハー ウント カンパニー カーゲー 難溶性化合物から水分散性の乾燥粉末を生成するための製法
WO2006022187A1 (ja) 2004-08-24 2006-03-02 Nisshin Pharma Inc. コエンザイムｑ10含有組成物
CN1969833A (zh) * 2005-11-25 2007-05-30 浙江医药股份有限公司新昌制药厂 含辅酶q10的干粉组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
TW200302055A (en) * 2002-01-18 2003-08-01 Kaneka Corp Ubiquinol-enriched fat-containing foods
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
US20050092969A1 (en) * 2003-10-08 2005-05-05 Kaneka Corporation Method of stabilizing compound having quinone skeleton and stabilized composition
JPWO2005035477A1 (ja) * 2003-10-08 2007-11-22 株式会社カネカ キノン骨格を有する化合物の安定化方法及び安定化された組成物
WO2006075502A1 (ja) * 2004-12-24 2006-07-20 Kaneka Corporation 還元型補酵素ｑ１０を含有する固形製剤及びその製造方法
JP5140585B2 (ja) * 2006-06-22 2013-02-06 株式会社カネカ 還元型補酵素ｑ１０含有組成物およびその製造方法
TW200836771A (en) * 2006-10-31 2008-09-16 Kaneka Corp Particulate composition comprising bioactive substance and method of producing the same

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754116A (ja) * 1980-09-19 1982-03-31 Eisai Co Ltd Bunsannoyoicoq10ganjusoseibutsu
EP0065193A2 (de) * 1981-05-15 1982-11-24 BASF Aktiengesellschaft Verfahren zur Herstellung von feinverteilten, pulverförmigen Carotinoid- bzw. Retinoidpräparaten
JPS5951214A (ja) 1982-09-16 1984-03-24 Taiho Yakuhin Kogyo Kk バイオアベイラビリテイの高い薬剤の製造方法
JP2000212066A (ja) 1998-11-16 2000-08-02 Eisai Co Ltd 脂溶性物質の水性液剤
JP2003055203A (ja) 2001-08-10 2003-02-26 Nisshin Pharma Inc ユビキノン含有製剤
JP3575762B2 (ja) 2001-09-25 2004-10-13 日清ファルマ株式会社 コエンザイムｑ１０を含有する栄養組成物
JP2003169630A (ja) * 2001-09-25 2003-06-17 Nisshin Pharma Inc コエンザイムｑ１０を含有する栄養組成物
JP2005524635A (ja) * 2002-02-08 2005-08-18 アボット ゲーエムベーハー ウント カンパニー カーゲー 難溶性化合物から水分散性の乾燥粉末を生成するための製法
JP2003238396A (ja) 2002-02-21 2003-08-27 Nisshin Pharma Inc コエンザイムｑ１０含有乳化組成物
JP2003321352A (ja) * 2002-04-24 2003-11-11 Nisshin Pharma Inc コエンザイムｑ１０含有組成物
JP2004075664A (ja) * 2002-06-20 2004-03-11 Nisshin Kyorin Pharmaceutical Co Ltd コエンザイムｑ１０を含有する経管経腸栄養剤
WO2006022187A1 (ja) 2004-08-24 2006-03-02 Nisshin Pharma Inc. コエンザイムｑ10含有組成物
CN1969833A (zh) * 2005-11-25 2007-05-30 浙江医药股份有限公司新昌制药厂 含辅酶q10的干粉组合物及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] XP008118662, retrieved from STN Database accession no. (2007:597834) *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522835A (ja) * 2009-04-06 2012-09-27 コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー コエンザイムｑ１０ナノ粒子、その製造方法及び上記ナノ粒子を含む組成物
JP2011055805A (ja) * 2009-09-14 2011-03-24 Sanei Gen Ffi Inc 魚肉の着色方法
WO2015186729A1 (ja) * 2014-06-03 2015-12-10 カルピス株式会社 錠剤型即放性製剤、錠剤用組成物及び錠剤型即放性製剤の製造方法
JP2016011285A (ja) * 2014-06-03 2016-01-21 カルピス株式会社 錠剤型即放性製剤及びその製造方法
CN106535916A (zh) * 2014-06-03 2017-03-22 朝日可尔必思健康株式会社 片剂型速释性制剂、片剂用组合物及片剂型速释性制剂的制造方法
US9675666B2 (en) 2014-06-03 2017-06-13 Asahi Calpis Wellness Co., Ltd. Immediate-release tablet formulation, composition for tablets and method for manufacturing immediate-release tablet formulation
JP2024517556A (ja) * 2021-03-17 2024-04-23 ユ，ヒョギョン コエンザイムｑ１０含有液状補助飼料組成物
US20240148026A1 (en) * 2021-03-17 2024-05-09 Hyo Gyoung Yu Liquid-phase, supplementary feed composition containing coenzyme q10
JP7809717B2 (ja) 2021-03-17 2026-02-02 ユ，ヒョギョン コエンザイムｑ１０含有液状補助飼料組成物
US12557829B2 (en) * 2021-03-17 2026-02-24 Hyo Gyoung Yu Liquid-phase, supplementary feed composition containing coenzyme Q10

Also Published As

Publication number Publication date
EP2172196A1 (en) 2010-04-07
US20090004170A1 (en) 2009-01-01
JP5377304B2 (ja) 2013-12-25
EP2172196B1 (en) 2020-03-25
TW200916090A (en) 2009-04-16
EP2172196A4 (en) 2012-10-17
JPWO2009001787A1 (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
WO2009001787A1 (ja) 補酵素ｑ１０含有組成物
WO2009001786A1 (ja) 生理活性物質含有組成物
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
WO2009007273A3 (en) A colouring composition comprising starch derivatives as a hydrocolloid
WO2008153945A3 (en) Nutraceutical co-crystal compositions
PH12014502353A1 (en) Supplementation of maternal diet
WO2006112714A3 (en) Uronic acid and probiotics
HU0500582D0 (en) Foods food-additives and nutriment supplements or feed-additives with synergetic physiological effect
EP1991068B8 (en) Isotopically modified compounds and their use as food supplements
IN2012DN00713A (ja)
WO2010066012A3 (en) Nutriment containing arabinoxylan and oligosaccharides
NZ589988A (en) Heat-stable, aqueous lactoferrin composition and its preparation and use
WO2009100241A3 (en) Systems for and methods of use of therapeutic nutrition for the management of age-associated and age-specific health conditions of the elderly.
WO2006112716A3 (en) Nutritional supplement for hiv patients
ZA201004224B (en) Production of food products with enhanced in mouth and mental refreshment
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2008105113A1 (ja) 口腔内用殺菌剤、及び該殺菌剤を含有する食品添加剤
WO2008129980A1 (ja) 還元型補酵素ｑ１０含有粒子状組成物及びその製造方法
MY161175A (en) Nutritional compositions having solid particles and methods for making and using same
EP2090302A4 (en) DIETETIC SUPPLEMENT, ANTI-FATIGUE AGENT, PHYSICAL ENDURANCE ACTIVATOR, FUNCTIONAL FOOD, OR COSMETIC PRODUCT
AU319556S (en) Container
WO2007109071A3 (en) Hydroxylated polymethoxyflavone compositions
WO2008036719A3 (en) Animal feed supplements and uses thereof
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2006130844A3 (en) Fucoidan delivery system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765784

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009520569

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008765784

Country of ref document: EP